• Action
• Comedy
• Thriller

Novocaine 2025

Novocaine is a 2025 American action‑comedy thriller directed by Dan Berk & Robert Olsen, from a screenplay by Lars Jacobson. The story follows Nathan Caine (Jack Quaid), a mild-mannered bank assistant manager born with congenital insensitivity to pain (CIPA). When his crush Sherry (Amber Midthunder) is taken hostage during a bank robbery, Nathan turns his inability to feel pain into an unexpected advantage on a chaotic rescue mission.📅 Release & Availability Released in the U.S. by Paramount on March 14, 2025. Opened to modest box office returns: ≈ $34 million worldwide on an $18 million budget. Available to buy/rent on digital platforms (Amazon Prime, Apple TV, Fandango) from April 8, 2025, priced around $24.99 (buy) / $19.99 (rent). Streaming on Paramount+ as of mid-May 2025.🌟 Critics & Reviews 📊 Critical Response Rotten Tomatoes: ~82–84% (Certified Fresh), average critic rating ~6.6/10. Metacritic: ~59/100.📰 Selected Critic Reviews Associated Press: Praised its bloody, comedic action—called it comparable to a lighter John Wick with comedy twist, giving 2.5/4 stars. Washington Post: Criticized it for excessive gore, flat cinematography, superficial depth despite good performances—called it “numbingly bland” at 1.5/4 stars.🗣 Audience Perspectives (Reddit Highlights) General consensus: A fun, concept‑driven romp with strong lead performance and inventive gore, though lacking depth:“Fun gimmick movie… Jack Quaid had tons of charisma”“Novocaine - 10/10. A purely fun, charming, and entertaining film!”“It is all just a long chain of very predictable cliché moments just to get those torture porn moments.”🎯 Who It’s For Fans of action‑comedy hybrids with a strong physical hook. Viewers who enjoy Jack Quaid’s charm and chemistry with Amber Midthunder. Those unbothered by graphic violence and interested in unconventional love-meets-vengeance tales.🎬 Opening Weekend (March 14–16, 2025) Domestic debut: ~$8.7 million across 3,365 North American theaters—lower than expected ($10M–12M), but still claimed the No. 1 spot amid the year’s lowest-grossing weekend to date ($54–55 million total box office). Per‑screen average: Approximately $2,585. Opening day: About $3.9 million, including previews (~$1.5–1.8M). Word-of-mouth indicators were positive: Rotten Tomatoes ~82%, PostTrak 84% positive, CinemaScore “B”.📉 Domestic & International Domestically, the total ended around $19.9 million in the U.S. and Canada. In week two, revenue dropped ~58%, earning ~$3.7M and placing fourth in the box office. Internationally, about $1.8 million was earned across 19 markets during the opening frame, including Mexico ($607K), South Korea ($154K), and Indonesia (~$126K). Worldwide total gross: Approximately $34.2–34.5 million ($19.9M domestic + $14.3–14.6M international).✅ Conclusion Novocaine (2025) is a bold, violent, and darkly comedic action-thriller that leans heavily on its unique premise—centering on a man who can't feel pain. Jack Quaid delivers a charismatic performance that helps ground the film’s over-the-top action and gore. While critics were mixed—praising its energy but critiquing its lack of depth—the film found a niche audience who appreciated its blend of absurdity, heart, and spectacle. If you enjoy high-concept action comedies with graphic violence, a quirky romantic thread, and a protagonist who's practically unkillable, Novocaine is worth a watch—especially on streaming. Just don’t expect anything too profound beneath the blood-soaked fun. Read More

• 2025
• 1 h : 49 min
• 316 views
• 6.478
• R